Unité de Fabrication des Médicaments S.A (BVMT:UMED)
9.90
-0.05 (-0.50%)
At close: Jun 15, 2026
BVMT:UMED Balance Sheet
Financials in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.97 | 21.01 | 5.98 | 5.98 | 3.69 |
Cash & Short-Term Investments | 8.97 | 21.01 | 5.98 | 5.98 | 3.69 |
Cash Growth | -57.33% | 251.29% | 0.06% | 62.11% | 26.21% |
Accounts Receivable | 36.67 | 36.65 | 39.46 | 33.94 | 26.39 |
Other Receivables | 15.74 | 14.36 | 8.52 | 10.37 | 7.85 |
Receivables | 52.41 | 51.02 | 47.98 | 44.32 | 34.24 |
Inventory | 46.45 | 47.64 | 50.22 | 44.14 | 34.59 |
Prepaid Expenses | 0.4 | 0.31 | 0.5 | 0.46 | 0.19 |
Other Current Assets | 4.31 | 5.56 | 8.74 | 5.49 | 4.42 |
Total Current Assets | 118.13 | 129.08 | 113.42 | 100.38 | 77.13 |
Property, Plant & Equipment | 75.53 | 79.71 | 74.9 | 71.67 | 66.46 |
Long-Term Investments | 1.26 | 3.29 | 5.23 | 7.29 | 7.44 |
Other Intangible Assets | 0.55 | 0.79 | 1.03 | 0.81 | 0.74 |
Long-Term Deferred Charges | 3.89 | 2.45 | 1.08 | 1.43 | 0.07 |
Other Long-Term Assets | 1.21 | 0.95 | 2.5 | 2.25 | 2.63 |
Total Assets | 200.58 | 216.28 | 198.18 | 183.86 | 154.48 |
Accounts Payable | 9.71 | 22.29 | 29.08 | 16.8 | 10.6 |
Accrued Expenses | 19.06 | 17.5 | 20.55 | 6.4 | 5.55 |
Short-Term Debt | 19.98 | 22.24 | 6.46 | 22.72 | 0.39 |
Current Portion of Long-Term Debt | 7.12 | 7.72 | 22.91 | 6.95 | 5.33 |
Current Portion of Leases | 0.86 | 0.88 | - | 0.22 | 0.39 |
Current Unearned Revenue | - | 0.13 | 0.02 | - | - |
Other Current Liabilities | 0.03 | 0.1 | 0.71 | 0.02 | 0.01 |
Total Current Liabilities | 56.82 | 70.85 | 79.74 | 53.11 | 22.27 |
Long-Term Debt | 17.11 | 23.57 | 21.83 | 25.25 | 21.62 |
Long-Term Leases | 0.48 | 1.34 | 0.33 | 0.08 | 0.3 |
Other Long-Term Liabilities | 9.62 | 4.31 | 2.02 | 1.73 | 1.45 |
Total Liabilities | 84.03 | 100.07 | 103.93 | 80.17 | 45.64 |
Common Stock | 32 | 32 | 32 | 32 | 32 |
Retained Earnings | 69.37 | 69.01 | 47.03 | 56.49 | 61.66 |
Comprehensive Income & Other | 15.18 | 15.2 | 15.23 | 15.21 | 15.17 |
Shareholders' Equity | 116.54 | 116.21 | 94.25 | 103.7 | 108.83 |
Total Liabilities & Equity | 200.58 | 216.28 | 198.18 | 183.86 | 154.48 |
Total Debt | 45.56 | 55.74 | 51.53 | 55.22 | 28.03 |
Net Cash (Debt) | -36.59 | -34.73 | -45.55 | -49.24 | -24.34 |
Net Cash Per Share | -1.14 | -1.09 | -1.42 | -1.54 | -0.76 |
Filing Date Shares Outstanding | 32 | 32 | 32 | 32 | 32 |
Total Common Shares Outstanding | 32 | 32 | 32 | 32 | 32 |
Working Capital | 61.3 | 58.23 | 33.68 | 47.28 | 54.85 |
Book Value Per Share | 3.64 | 3.63 | 2.95 | 3.24 | 3.40 |
Tangible Book Value | 116 | 115.42 | 93.23 | 102.88 | 108.1 |
Tangible Book Value Per Share | 3.62 | 3.61 | 2.91 | 3.22 | 3.38 |
Land | 4.22 | 4.22 | 4.22 | 4.22 | 4.22 |
Buildings | 10.92 | 10.92 | 8.72 | 10.68 | 10.62 |
Machinery | 140.89 | 141.04 | 131.46 | 30.77 | 28.9 |
Construction In Progress | 49.41 | 46.61 | 43.89 | 25.93 | 19.43 |